Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
While the case will proceed, the federal court agreed in part with a UnitedHealth Group motion and dismissed some claims.